193 related articles for article (PubMed ID: 24244525)
1. TAP mediates import of Mycobacterium tuberculosis-derived peptides into phagosomes and facilitates loading onto HLA-I.
Harriff MJ; Burgdorf S; Kurts C; Wiertz EJ; Lewinsohn DA; Lewinsohn DM
PLoS One; 2013; 8(11):e79571. PubMed ID: 24244525
[TBL] [Abstract][Full Text] [Related]
2. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle.
Grotzke JE; Harriff MJ; Siler AC; Nolt D; Delepine J; Lewinsohn DA; Lewinsohn DM
PLoS Pathog; 2009 Apr; 5(4):e1000374. PubMed ID: 19360129
[TBL] [Abstract][Full Text] [Related]
3. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
[TBL] [Abstract][Full Text] [Related]
4. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
5. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
[TBL] [Abstract][Full Text] [Related]
6. Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway.
Lewinsohn DM; Grotzke JE; Heinzel AS; Zhu L; Ovendale PJ; Johnson M; Alderson MR
J Immunol; 2006 Jul; 177(1):437-42. PubMed ID: 16785540
[TBL] [Abstract][Full Text] [Related]
7. TAP-Dependent and -Independent Peptide Import into Dendritic Cell Phagosomes.
Lawand M; Abramova A; Manceau V; Springer S; van Endert P
J Immunol; 2016 Nov; 197(9):3454-3463. PubMed ID: 27664280
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
Schaible UE; Winau F; Sieling PA; Fischer K; Collins HL; Hagens K; Modlin RL; Brinkmann V; Kaufmann SH
Nat Med; 2003 Aug; 9(8):1039-46. PubMed ID: 12872166
[TBL] [Abstract][Full Text] [Related]
9. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
Bian Y; Shang S; Siddiqui S; Zhao J; Joosten SA; Ottenhoff THM; Cantor H; Wang CR
PLoS Pathog; 2017 May; 13(5):e1006384. PubMed ID: 28475642
[TBL] [Abstract][Full Text] [Related]
10. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation.
Ramachandra L; Noss E; Boom WH; Harding CV
J Exp Med; 2001 Nov; 194(10):1421-32. PubMed ID: 11714749
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
[TBL] [Abstract][Full Text] [Related]
12. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
13. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
Levitt JM; Howell DD; Rodgers JR; Rich RR
Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
[TBL] [Abstract][Full Text] [Related]
14. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
Li S; Paulsson KM; Sjögren HO; Wang P
J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
[TBL] [Abstract][Full Text] [Related]
15. Class II MHC antigen processing in phagosomes.
Ramachandra L; Boom WH; Harding CV
Methods Mol Biol; 2008; 445():353-77. PubMed ID: 18425462
[TBL] [Abstract][Full Text] [Related]
16. Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells.
Martín-Galiano AJ; López D
PLoS One; 2019; 14(1):e0210583. PubMed ID: 30645615
[TBL] [Abstract][Full Text] [Related]
17. HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8
Harriff MJ; Wolfe LM; Swarbrick G; Null M; Cansler ME; Canfield ET; Vogt T; Toren KG; Li W; Jackson M; Lewinsohn DA; Dobos KM; Lewinsohn DM
Sci Rep; 2017 Jul; 7(1):4622. PubMed ID: 28676677
[TBL] [Abstract][Full Text] [Related]
18. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
[TBL] [Abstract][Full Text] [Related]
19. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8
Abdulhaqq SA; Wu H; Schell JB; Hammond KB; Reed JS; Legasse AW; Axthelm MK; Park BS; Asokan A; Früh K; Hansen SG; Picker LJ; Sacha JB
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
